Literature DB >> 22448810

Early effect of oral administration of omeprazole with mosapride as compared with those of omeprazole alone on the intragastric pH.

Hiroshi Iida1, Masahiko Inamori, Tetsuro Fujii, Yusuke Sekino, Hiroki Endo, Kunihiro Hosono, Takashi Nonaka, Tomoko Koide, Hirokazu Takahashi, Masato Yoneda, Ayumu Goto, Yasunobu Abe, Noritoshi Kobayashi, Hiroyuki Kirikoshi, Kensuke Kubota, Satoru Saito, Eiji Gotoh, Shin Maeda, Atsushi Nakajima.   

Abstract

BACKGROUND: The ideal medication for acid-related diseases should have a rapid onset of action to promote hemostasis and cause efficient resolution of symptoms. The aim of our study was to comparatively investigate the inhibitory effect on gastric acid secretion of a single oral administration of omeprazole plus mosapride with that of omeprazole alone.
METHODS: Ten Helicobacter pylori-negative male subjects participated in this randomized, two-way crossover study. Intragastric pH was monitored continuously for 6 hours after a single oral administration of omeprazole 20 mg or that of omeprazole 20 mg plus mosapride 5 mg (the omeprazole being administered one hour after the mosapride). Each administration was separated by a 7-days washout period.
RESULTS: The average pH during the 6-hour period after administration of omeprazole 20 mg plus mosapride 5 mg was higher than that after administration of omeprazole 20 mg alone (median: 3.22 versus 4.21, respectively; p = 0.0247).
CONCLUSIONS: In H. pylori -negative healthy male subjects, an oral dose of omeprazole 20 mg plus mosapride 5 mg increased the intragastric pH more rapidly than omeprazole 20 mg alone.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22448810      PMCID: PMC3342890          DOI: 10.1186/1471-230X-12-25

Source DB:  PubMed          Journal:  BMC Gastroenterol        ISSN: 1471-230X            Impact factor:   3.067


  14 in total

1.  The comparative effects of single intravenous doses of omeprazole and famotidine on intragastric pH.

Authors:  Yasunobu Abe; Masahiko Inamori; Jun-Ichi Togawa; Taisuke Kikuchi; Kenichi Muramatsu; Gaku Chiguchi; Harunobu Kawamura; Noritoshi Kobayashi; Hiroyuki Kirikoshi; Takashi Sakaguchi; Tomoo Takamura; Atsushi Nakajima; Norio Ueno; Hisahiko Sekihara
Journal:  J Gastroenterol       Date:  2004-01       Impact factor: 7.527

2.  [New preparation method for barium enema: efficacy and administration of oral intestinal lavage solution with gastrointestinal prokinetic agent].

Authors:  Shinichi Futei; Yoshinori Sugino; Sachio Kuribayashi; Yutaka Imai; Fumiaki Ueno; Toshifumi Hibi; Toru Mitsushima
Journal:  Nihon Igaku Hoshasen Gakkai Zasshi       Date:  2004-01

3.  AS-4370, a new gastrokinetic agent, enhances upper gastrointestinal motor activity in conscious dogs.

Authors:  N Yoshida; T Ito; T Karasawa; Z Itoh
Journal:  J Pharmacol Exp Ther       Date:  1991-05       Impact factor: 4.030

4.  Evaluation of the effects of anti-secretory drugs on intragastric acidity: is combined therapy with a proton pump inhibitor and an H2 receptor antagonist effective as initial treatment?

Authors:  Masahiko Inamori; Jun-ichi Togawa; Gaku Chiguchi; Yasunobu Abe; Taisuke Kikuchi; Kenichi Muramatsu; Harunobu Kawamura; Noritoshi Kobayashi; Hiroyuki Kirikoshi; Takeshi Shimamura; Takashi Sakaguchi; Tomoo Takamura; Norio Ueno; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2005-02       Impact factor: 7.527

5.  Effect of acid and pepsin on blood coagulation and platelet aggregation. A possible contributor prolonged gastroduodenal mucosal hemorrhage.

Authors:  F W Green; M M Kaplan; L E Curtis; P H Levine
Journal:  Gastroenterology       Date:  1978-01       Impact factor: 22.682

6.  AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties.

Authors:  N Yoshida; H Omoya; M Oka; K Furukawa; T Ito; T Karasawa
Journal:  Arch Int Pharmacodyn Ther       Date:  1989 Jul-Aug

7.  Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use?

Authors:  Masahiko Inamori; Jun-Ichi Togawa; Tomoyuki Iwasaki; Yutaka Ozawa; Taisuke Kikuchi; Kenichi Muramatsu; Gaku Chiguchi; Shuhei Matsumoto; Harunobu Kawamura; Yasunobu Abe; Hiroyuki Kirikoshi; Noritoshi Kobayashi; Takeshi Shimamura; Kensuke Kubota; Takashi Sakaguchi; Satoru Saito; Norio Ueno; Atsushi Nakajima
Journal:  J Gastroenterol       Date:  2005-05       Impact factor: 7.527

8.  Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression.

Authors:  D W Burget; S G Chiverton; R H Hunt
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

9.  The effect of mosapride, a novel prokinetic, on acid reflux variables in patients with gastro-oesophageal reflux disease.

Authors:  M Ruth; B Hamelin; K Röhss; L Lundell
Journal:  Aliment Pharmacol Ther       Date:  1998-01       Impact factor: 8.171

10.  Early effects of oral administration of lafutidine with mosapride compared with lafutidine alone on intragastric pH values.

Authors:  Hiroshi Iida; Masahiko Inamori; Yuichi Nozaki; Hiroki Endo; Kunihiro Hosono; Tomoyuki Akiyama; Yasunari Sakamoto; Hirokazu Takahashi; Tomoko Koide; Chikako Tokoro; Yasunobu Abe; Atsushi Nakajima
Journal:  BMC Gastroenterol       Date:  2009-07-09       Impact factor: 3.067

View more
  3 in total

1.  Effects of mosapride on esophageal motor activity and esophagogastric junction compliance in healthy volunteers.

Authors:  Kousuke Fukazawa; Kenji Furuta; Kyoichi Adachi; Yoshiya Moritou; Tsukasa Saito; Ryusaku Kusunoki; Goichi Uno; Shino Shimura; Masahito Aimi; Shunji Ohara; Shunji Ishihara; Yoshikazu Kinoshita
Journal:  J Gastroenterol       Date:  2013-09-07       Impact factor: 7.527

2.  Early effect on intragastric pH of oral administration of rabeprazole with mosapride compared with rabeprazole alone.

Authors:  Hiroshi Iida; Megumi Kaai; Yumi Inoh; Kenji Kanoshima; Kanji Ohkuma; Takashi Nonaka; Koji Fujita; Tomonori Ida; Akihiko Kusakabe; Shin Maeda; Atsushi Nakajima; Masahiko Inamori
Journal:  Ann Gastroenterol       Date:  2017-05-19

3.  Current pharmacological management of gastroesophageal reflux disease.

Authors:  Yao-Kuang Wang; Wen-Hung Hsu; Sophie S W Wang; Chien-Yu Lu; Fu-Chen Kuo; Yu-Chung Su; Sheau-Fang Yang; Chiao-Yun Chen; Deng-Chyang Wu; Chao-Hung Kuo
Journal:  Gastroenterol Res Pract       Date:  2013-06-26       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.